We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Correcting Glasses Reestablish Indoor Color Vision

By HospiMedica International staff writers
Posted on 31 Mar 2015
Innovative glasses enable red-green color vision deficiency (CVD) sufferers see digital display screens and status indicator lights when performing color-based activities.

The EnChroma Cx-65 eyewear for indoor use are based on Digital Color Boost (DCB), an optical coating technology for lenses that defines a series of precise “cutouts” along the spectrum of light, removing the wavelengths that sit between the primary colors and amplifying the color signal sent to the brain. More...
DCB coatings are made from up to 100 layers of dielectric material, with each individual layer only a few nanometers thick. Due to quantum interactions at the boundaries between layers, photons passing through the coating are selectively blocked, depending on their wavelength.

The EnChroma Cx line uses a special extra-strength version of the DCB coating that removes wavelengths of light where the overlap is occurring between the red and green cone cells. By doing so, the spectral shift can be reversed, amplifying the color signal sent to the brain. The result is that colors appear to be brighter and more pure, thousands of more shades can be seen, and they can be recognized more quickly and with less confusion. EnChroma Cx eyewear are products of EnChroma (Berkley, CA, USA), and are available as sunglasses as well.

“A lot of EnChroma sunglass wearers wanted an indoor version so they could bring the experience of seeing certain colors for the first time to their lives at work and at home,” said Tony Dykes, CEO of EnChroma. “Everything from learning at school or presenting a colorful slide show at work, to debating friends about the infamous 'gold-and-white or black-and-blue dress,' is much easier with EnChroma Cx indoor glasses.”

Red-green color blindness is caused by a genetic defect carried on the X-chromosome; the condition affects 8% of males and 0.4% of females. There are two types of red-green color blindness; deutans, which are 75% of cases, have a defect in the green cone cells; the defect causes the green cone cell to be spectrally shifted towards red (green becomes more like yellow). Protans, which are 25% of cases, have a defect in the red cone cells which causes the red cone cell to be spectrally shifted towards green (red becomes darker and more like orange).

Related Links:

EnChroma



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.